A Study of Ixabepilone as Second-line Therapy for Locally Advanced, Recurrent, or Metastatic Endometrial Cancer
A phase 3 trial of Ixabepilone, Doxorubicin and Paclitaxel / nab-paclitaxel in Endometrial cancer, run by R-Pharm, recorded as terminated on the registry.
Overview
A Study of Ixabepilone as Second-line Therapy for Locally Advanced, Recurrent, or Metastatic Endometrial Cancer is a phase 3 interventional study registered as NCT00883116 by R-Pharm, with 551 participants recorded, started 2009-08 and due to reach its primary completion in 2012-06. Interventions recorded: Ixabepilone, Doxorubicin, Paclitaxel. Conditions recorded: Endometrial Cancer.
Linked to the drug Ixabepilone because the registry names it among its interventions and Endometrial cancer among its conditions. Registry record only: no result has been read by an editor.
Similar pages
not linked directly; found by shared links- TrialCalcium and Magnesium in Preventing Peripheral Neuropathy Caused by Ixabepilone in Patients With Breast Cancer
Shares Ixabepilone and the tag pipeline.
- TrialA Study to Investigate Mocertatug Rezetecan Compared With Chemotherapy in Participants With Endometrial Cancer After Platinum-based Chemotherapy and Immunotherapy (BEHOLD-Endometrial01)
Shares Doxorubicin, Endometrial cancer and the tag pipeline.
- TreatmentRPH-051
Shares R-Pharm and the tag pipeline.
- TrialSafety and Efficacy Comparison of Docetaxel and Ixabepilone in Non Metastatic Poor Prognosis Breast Cancer
Shares Ixabepilone and the tag pipeline.
- TrialA Study of E7386 in Combination With Other Anticancer Drug(s) in Participants With Solid Tumor
Shares Doxorubicin, Endometrial cancer and the tag pipeline.
- TrialChemotherapy With or Without Trastuzumab After Surgery in Treating Women With Invasive Breast Cancer
Shares Doxorubicin, Paclitaxel / nab-paclitaxel and the tag pipeline.
- TrialCombination Chemotherapy, Surgery, and Radiation Therapy With or Without Dexrazoxane and Trastuzumab in Treating Women With Stage III or Stage IV Breast Cancer
Shares Doxorubicin, Paclitaxel / nab-paclitaxel and the tag pipeline.
- TrialPlacebo Microneedles in Healthy Volunteers (Part I) and Efficacy/Safety of Doxorubicin Microneedles in Basal Cell Cancer Subjects (Part II)
Shares Doxorubicin and the tag pipeline.